MPM BIOIMPACT LLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1687078 BOSTON, MA

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$39,350,269

-$1,804,060 QoQ

Shares Held

3,298,430

+0.3% QoQ

Ownership

2.32%

of shares outstanding

% of Portfolio

3.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MPM BIOIMPACT LLC holds $1,223,258,298 across 39 Biotechnology names. TRVI ranks #9 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DBVT	DBV Technologies S.A.	5,213,361	$108,907,111
2	CGEM	Cullinan Therapeutics, Inc.	7,648,268	$108,681,888
3	AKTS	Aktis Oncology, Inc.	4,835,872	$86,513,750
4	ALMS	Alumis Inc.	2,386,529	$52,575,233
5	EWTX	Edgewise Therapeutics, Inc.	1,660,696	$52,311,924
6	RVMD	Revolution Medicines, Inc.	506,776	$49,283,966
7	AGIO	Agios Pharmaceuticals, Inc.	1,306,261	$44,190,809
8	CORT	Corcept Therapeutics Inc	985,700	$39,733,567

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,350,269	3,298,430	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$41,154,329	3,287,087	-3.5%	Shares	Sole	2026-02-17
2025-09-30	$31,173,638	3,406,955	0.0%	Shares	Sole	2025-11-14
2025-06-30	$18,636,043	3,406,955	-0.6%	Shares	Sole	2025-08-14
2025-03-31	$21,564,422	3,428,366	+10.8%	Shares	Sole	2025-05-15
2024-12-31	$12,750,971	3,094,896	+101.2%	Shares	Sole	2025-02-14
2024-09-30	$5,138,646	1,538,517	+1.9%	Shares	Sole	2024-11-13
2024-06-30	$4,500,318	1,510,174	+12.6%	Shares	Sole	2024-08-14
2024-03-31	$4,626,312	1,340,960	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.